Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.
Type:
Application
Filed:
August 9, 2013
Publication date:
December 5, 2013
Applicant:
DexCom, Inc.
Inventors:
Apurv Ullas Kamath, Richard C. Yang, Jacob S. Leach, Nelson Quintana
Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.
Type:
Application
Filed:
August 9, 2013
Publication date:
December 5, 2013
Applicant:
DexCom, Inc.
Inventors:
Apurv Ullas Kamath, Richard C. Yang, Jacob S. Leach, Nelson Quintana
Abstract: Methods and apparatus, including computer program products, are provided for processing analyte data. In some exemplary implementations, there is provided a method. The method may include generating, by at least one processor, a view comprising an abstraction distilled from the sensor data over a time period. The view may further comprise a graphical representation comprising a plurality of different graphically distinct elements representative of whether the abstraction over the time period is at least one of at, above, or within a predetermined glucose concentration level for a host; a call out comprising value help for the graphical representation, and a textual legend comprising a description of the graphical representation and the abstraction. The method may further include providing the view as a module. Related systems, methods, and articles of manufacture are also disclosed.
Type:
Application
Filed:
March 7, 2013
Publication date:
December 5, 2013
Applicant:
DexCom, Inc.
Inventors:
Adam R. Greene, Justin E. Schumacher, Daniel N. Root
Abstract: Methods and apparatus, including computer program products, are provided for processing analyte data. In some exemplary implementations, there is provided a method. The method may include selecting at least one module from among a plurality of modules, the selection performed based on metadata including one or more of the following rules: whether the at least one module can be used with a type of device, whether the at least one module can be used with a glycemic state of a host, and whether the at least one module can be used with an expected volume of data generated by the type of device; and generating a report including the selected at least one module configured to present information representative of the glucose concentration level measured in the host. Related systems, methods, and articles of manufacture are also disclosed.
Type:
Application
Filed:
March 7, 2013
Publication date:
December 5, 2013
Applicant:
DexCom, Inc.
Inventors:
Adam R. Greene, Justin E. Schumacher, Daniel N. Root
Abstract: Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.
Type:
Grant
Filed:
February 20, 2009
Date of Patent:
November 26, 2013
Assignee:
DexCom, Inc.
Inventors:
Michael Robert Mensinger, John Michael Dobbles, Apurv U. Kamath, Beat Stadelmann, Deborah M. Ruppert, Nasser Salamati, Richard C. Yang
Abstract: Membrane systems incorporating silicone polymers are described for use in implantable analyte sensors. Some layers of the membrane system may comprise a blend of a silicone polymer with a hydrophilic polymer, for example, a triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymer. Such polymeric blends provide for both high oxygen solubility and aqueous analyte solubility.
Abstract: Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.
Type:
Application
Filed:
July 23, 2013
Publication date:
November 21, 2013
Applicant:
DexCom, Inc.
Inventors:
Mark C. Shults, Stuart J. Updike, Rathbun K Rhodes, Barbara J. Gilligan, Mark A. Tapsak
Abstract: Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.
Type:
Grant
Filed:
December 16, 2009
Date of Patent:
November 19, 2013
Assignee:
DexCom, Inc.
Inventors:
Apurv Ullas Kamath, Paul V. Goode, Jr., James H. Brauker, Victoria E. Carr-Brendel
Abstract: Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor.
Type:
Grant
Filed:
January 7, 2010
Date of Patent:
November 12, 2013
Assignee:
DexCom, Inc.
Inventors:
Apurv Ullas Kamath, Paul V. Goode, James H. Brauker
Abstract: Devices and methods are described for providing continuous measurement of an analyte concentration. In some embodiments, the device has a sensing mechanism and a sensing membrane that includes at least one surface-active group-containing polymer and that is located over the sensing mechanism. The sensing membrane may have a bioprotective layer configured to substantially block the effect and/or influence of non-constant noise-causing species.
Type:
Grant
Filed:
March 5, 2010
Date of Patent:
November 12, 2013
Assignee:
DexCom, Inc.
Inventors:
Robert Boock, Monica A. Rixman, Huashi Zhang, Michael J. Estes, Kristina Lawrence
Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
Type:
Grant
Filed:
May 14, 2010
Date of Patent:
October 29, 2013
Assignee:
DexCom, Inc.
Inventors:
Apurv Ullas Kamath, James Brauker, J. Michael Dobbles
Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.
Type:
Grant
Filed:
June 5, 2008
Date of Patent:
October 22, 2013
Assignee:
DexCom, Inc.
Inventors:
Apurv U. Kamath, Richard C. Yang, Jacob S. Leach, Nelson Quintana
Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
Type:
Grant
Filed:
May 14, 2010
Date of Patent:
October 22, 2013
Assignee:
DexCom, Inc.
Inventors:
Apurv Ullas Kamath, James Brauker, J. Michael Dobbles
Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.
Type:
Grant
Filed:
November 7, 2008
Date of Patent:
October 22, 2013
Assignee:
Dexcom, Inc.
Inventors:
Jacob S. Leach, Peter C. Simpson, Richard C. Yang, Mark Brister
Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
Type:
Grant
Filed:
May 7, 2009
Date of Patent:
October 22, 2013
Assignee:
DexCom, Inc.
Inventors:
Mark Brister, Steve Masterson, J. Michael Dobbles, Michael Robert Mensinger, Sean Saint, Apurv Ullas Kamath, James Brauker
Abstract: Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor.
Type:
Grant
Filed:
March 26, 2010
Date of Patent:
October 15, 2013
Assignee:
DexCom, Inc.
Inventors:
Paul V. Goode, Jr., James H. Brauker, Apurv U. Kamath
Abstract: Systems and methods of use involving sensors having a particle-containing domain are provided for continuous analyte measurement in a host. In some embodiments, a continuous analyte measurement system is configured to be wholly, transcutaneously, intravascularly or extracorporeally implanted.
Type:
Grant
Filed:
September 17, 2009
Date of Patent:
October 15, 2013
Assignee:
DexCom, Inc.
Inventors:
Peter C. Simpson, Robert J. Boock, Matthew Wightlin, Mark C. Shults
Abstract: The present embodiments relate generally to systems and methods for measuring an analyte in a host. More particularly, the present embodiments provide sensor applicators and methods of use with pushbutton activation that implant the sensor, withdraw the insertion needle, engage the transmitter with the housing, and disengage the applicator from the housing, all in one smooth motion. Some embodiments contemplate engagement of the transmitter with the housing after release of the applicator.
Type:
Application
Filed:
March 14, 2013
Publication date:
October 10, 2013
Applicant:
DexCom, Inc.
Inventors:
Jack Pryor, Sebastian Bohm, David DeRenzy, Jason Halac, Daniel S. Kline, Phong Lieu, Adam J. Livingston, Steve Masterson, Paul V. Neale, Peter C. Simpson, Antonio Joao Ubach
Abstract: The present embodiments relate generally to systems and methods for measuring an analyte in a host. More particularly, the present embodiments provide sensor applicators and methods of use with pushbutton activation that implant the sensor, withdraw the insertion needle, engage the transmitter with the housing, and disengage the applicator from the housing, all in one smooth motion. Some embodiments contemplate engagement of the transmitter with the housing after release of the applicator.
Type:
Application
Filed:
March 14, 2013
Publication date:
October 10, 2013
Applicant:
DexCom, Inc.
Inventors:
Jack Pryor, Sebastian Bohm, David DeRenzy, Jason Halac, Daniel S. Kline, Phong Lieu, Adam J. Livingston, Steve Masterson, Paul V. Neale, Peter C. Simpson, Antonio Joao Ubach
Abstract: The present embodiments relate generally to systems and methods for measuring an analyte in a host. More particularly, the present embodiments provide sensor applicators and methods of use with pushbutton activation that implant the sensor, withdraw the insertion needle, engage the transmitter with the housing, and disengage the applicator from the housing, all in one smooth motion. Some embodiments contemplate engagement of the transmitter with the housing after release of the applicator.
Type:
Application
Filed:
March 14, 2013
Publication date:
October 10, 2013
Applicant:
DexCom, Inc.
Inventors:
Jack Pryor, Sebastian Bohm, David DeRenzy, Jason Halac, Daniel S. Kline, Phong Lieu, Adam J. Livingston, Steve Masterson, Paul V. Neale, Peter C. Simpson, Antonio Joao Ubach